Viridian Therapeutics, Inc.\DE (VRDN) Change in Acquisitions & Divestments (2018 - 2026)

Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $168.6 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 1.63% year-over-year to $168.6 million in Q1 2026; TTM through Mar 2026 was $539.4 million, a 2.94% decrease from a year earlier, with the FY2025 full-year figure at $542.2 million, up 16.12% from the prior year.
• Change in Acquisitions & Divestments climbed to $168.6 million in Q1 2026 per VRDN's latest filing, from $99.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $171.4 million in Q1 2025 and bottomed at $14.2 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $99.0 million (2025), against an average of $94.2 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 2968.21% in 2022; the steepest drop was 78.92% in 2022.
• Year by year, Change in Acquisitions & Divestments stood at $37.7 million in 2022, then soared by 172.76% to $102.8 million in 2023, then gained by 15.7% to $119.0 million in 2024, then decreased by 16.78% to $99.0 million in 2025, then jumped by 70.29% to $168.6 million in 2026.
• Per Business Quant, the three latest VRDN Change in Acquisitions & Divestments figures stand at $168.6 million (Q1 2026), $99.0 million (Q4 2025), and $140.3 million (Q3 2025).